The provision of drugs that have recently lost exclusivity, namely Aflibercept; Dapagliflozin; Golimumab
- Procurement
- Transitional Drugs 5
- Buyer
- NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
- Published
- 8 Dec 2025
- Status
- complete
- CPV
- —
- Tender period
- —
Awards
Other notices in this procurement
FAQs about this notice
What type of notice is this?
This is a award,contract published via Find a Tender on 8 Dec 2025.
Which procurement does this notice belong to?
It is part of "Transitional Drugs 5", published by NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust).
Has this notice resulted in an award?
3 awards are recorded on this notice, including to Mercury Pharmaceuticals Limited.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable